.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Merck
Cantor Fitzgerald
Harvard Business School
Cerilliant
Novartis
Argus Health
Baxter
Medtronic
Fuji

Generated: September 25, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: darifenacin hydrobromide

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Macleods Pharms Ltd
DARIFENACIN
darifenacin hydrobromide
TABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals Limited33342-276-0730 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-276-07)
Macleods Pharms Ltd
DARIFENACIN
darifenacin hydrobromide
TABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals Limited33342-276-1090 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-276-10)
Macleods Pharms Ltd
DARIFENACIN
darifenacin hydrobromide
TABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals Limited33342-276-1210 BLISTER PACK in 1 CARTON (33342-276-12) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Macleods Pharms Ltd
DARIFENACIN
darifenacin hydrobromide
TABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals Limited33342-277-0730 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-277-07)
Macleods Pharms Ltd
DARIFENACIN
darifenacin hydrobromide
TABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals Limited33342-277-1090 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-277-10)
Macleods Pharms Ltd
DARIFENACIN
darifenacin hydrobromide
TABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals Limited33342-277-1210 BLISTER PACK in 1 CARTON (33342-277-12) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Torrent Pharms Ltd
DARIFENACIN HYDROBROMIDE
darifenacin hydrobromide
TABLET, EXTENDED RELEASE;ORAL205209ANDATorrent Pharmaceuticals Limited13668-202-05500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-05)
Torrent Pharms Ltd
DARIFENACIN HYDROBROMIDE
darifenacin hydrobromide
TABLET, EXTENDED RELEASE;ORAL205209ANDATorrent Pharmaceuticals Limited13668-202-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-30)
Torrent Pharms Ltd
DARIFENACIN HYDROBROMIDE
darifenacin hydrobromide
TABLET, EXTENDED RELEASE;ORAL205209ANDATorrent Pharmaceuticals Limited13668-202-74100 TABLET, EXTENDED RELEASE in 1 CARTON (13668-202-74)
Torrent Pharms Ltd
DARIFENACIN HYDROBROMIDE
darifenacin hydrobromide
TABLET, EXTENDED RELEASE;ORAL205209ANDATorrent Pharmaceuticals Limited13668-202-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-90)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Healthtrust
Daiichi Sankyo
Baxter
Cerilliant
Fish and Richardson
Deloitte
Express Scripts
QuintilesIMS
Accenture

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot